LifeTech Scientific Corporation (HKG:1302)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.510
-0.010 (-0.66%)
Jun 18, 2026, 4:08 PM HKT
Market Cap6.99B -6.8%
Revenue (ttm)1.52B +5.1%
Net Income164.50M -33.5%
EPS0.04 -35.0%
Shares Out 4.63B
PE Ratio41.12
Forward PE13.04
Dividendn/a
Ex-Dividend Daten/a
Volume19,149,000
Open1.500
Previous Close1.520
Day's Range1.460 - 1.510
52-Week Range1.460 - 2.440
Beta0.31
AnalystsStrong Buy
Price Target2.80 (+85.43%)
Earnings DateAug 28, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing,... [Read more]

Sector Healthcare
Founded 1999
Employees 1,245
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1302
Full Company Profile

Financial Performance

In 2025, LifeTech Scientific's revenue was 1.37 billion, an increase of 5.07% compared to the previous year's 1.30 billion. Earnings were 147.83 million, a decrease of -33.53%.

Financial numbers in CNY Financial Statements